Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · June 03, 2024

Outcomes of Chemotherapy With and Without Atezolizumab for Early Relapsing Unresectable Advanced TNBC

Annals of Oncology


Additional Info

Annals of Oncology
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
Ann. Oncol 2024 May 07;[EPub Ahead of Print], R Dent, F André, A Gonçalves, M Martin, P Schmid, F Schütz, S Kümmel, SM Swain, A Bilici, D Loirat, R Villalobos Valencia, SA Im, YH Park, M De Laurentis, M Colleoni, V Guarneri, G Bianchini, H Li, Z Kirchmayer Machackova, J Mouta, R Deurloo, X Gan, M Fan, A Mani, A Swat, J Cortés

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading